Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer

We evaluated the efficacy of dose de-escalation to the normal larynx using conformal radiotherapy (CRT) for T1/T2 glottic cancer. For conventional RT (2DRT, n = 38), the laryngeal box received a median equivalent dose in 2 Gy fractions (EQD2) of 66 Gy. For CRT (n = 42; 3D-CRT, 20; intensity-modulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jun Won, Byeon, Hyung Kwon, Choi, Hong-Shik, Lee, Ik Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691141/
https://www.ncbi.nlm.nih.gov/pubmed/29147004
http://dx.doi.org/10.1038/s41598-017-15974-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691141/
https://www.ncbi.nlm.nih.gov/pubmed/29147004
http://dx.doi.org/10.1038/s41598-017-15974-6

Ejemplares similares